ONE-WAYOngoing theme · still written in the latest filings
Risk of Delayed Product Launches and Failure to Recover Investments Due to R&D and Regulatory Approval Delays
The risk that delays or cancellations in research and development, failure to meet performance targets, or prolonged regulatory approval processes will delay the launch of products such as infectious disease genetic testing products, preventing the recovery of investments.
Companies3How many companies write about this.
Threads4One company can carry more than one thread here.
PeriodFY2016 →Still being written about.
Directionhurts0 helps · 4 hurts · 0 flat